Kangyue Technology Co Ltd (300391) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kangyue Technology Co Ltd (300391) has a cash flow conversion efficiency ratio of 0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-21.99 Million ≈ $-3.22 Million USD) by net assets (CN¥-667.62 Million ≈ $-97.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Kangyue Technology Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Kangyue Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Kangyue Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Kangyue Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kangyue Technology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
R. S. Software (India) Limited
NSE:RSSOFTWARE
|
-0.107x |
|
Viet Phat Import Export Trading Investment JSC
VN:VPG
|
N/A |
|
Lodestar Minerals Ltd
AU:LSR
|
3.339x |
|
Crown Point Energy Inc
V:CWV
|
-0.370x |
|
Brimstone Investment Corporation Ltd
JSE:BRT
|
0.023x |
|
Vistry Group PLC
LSE:VTY
|
0.059x |
|
Cielo Waste Solutions Corp
V:CMC
|
0.452x |
|
Sejin T.S Co.Ltd
KQ:067770
|
0.010x |
Annual Cash Flow Conversion Efficiency for Kangyue Technology Co Ltd (2009–2024)
The table below shows the annual cash flow conversion efficiency of Kangyue Technology Co Ltd from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Kangyue Technology Co Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥-421.36 Million ≈ $-61.66 Million |
CN¥-75.30 Million ≈ $-11.02 Million |
0.179x | +223.33% |
| 2023-12-31 | CN¥1.02 Billion ≈ $148.87 Million |
CN¥-147.43 Million ≈ $-21.57 Million |
-0.145x | -265.09% |
| 2022-12-31 | CN¥1.66 Billion ≈ $243.59 Million |
CN¥-66.08 Million ≈ $-9.67 Million |
-0.040x | -127.65% |
| 2021-12-31 | CN¥1.61 Billion ≈ $235.49 Million |
CN¥230.99 Million ≈ $33.80 Million |
0.144x | +534.18% |
| 2020-12-31 | CN¥1.45 Billion ≈ $212.10 Million |
CN¥32.81 Million ≈ $4.80 Million |
0.023x | -23.69% |
| 2019-12-31 | CN¥751.95 Million ≈ $110.03 Million |
CN¥22.30 Million ≈ $3.26 Million |
0.030x | -69.03% |
| 2018-12-31 | CN¥1.43 Billion ≈ $209.49 Million |
CN¥137.09 Million ≈ $20.06 Million |
0.096x | +129.55% |
| 2017-12-31 | CN¥933.89 Million ≈ $136.66 Million |
CN¥38.96 Million ≈ $5.70 Million |
0.042x | +184.07% |
| 2016-12-31 | CN¥362.88 Million ≈ $53.10 Million |
CN¥-18.01 Million ≈ $-2.63 Million |
-0.050x | -144.06% |
| 2015-12-31 | CN¥363.91 Million ≈ $53.25 Million |
CN¥40.98 Million ≈ $6.00 Million |
0.113x | +205.64% |
| 2014-12-31 | CN¥364.71 Million ≈ $53.37 Million |
CN¥-38.88 Million ≈ $-5.69 Million |
-0.107x | -197.21% |
| 2013-12-31 | CN¥197.50 Million ≈ $28.90 Million |
CN¥21.66 Million ≈ $3.17 Million |
0.110x | -35.51% |
| 2012-12-31 | CN¥172.54 Million ≈ $25.25 Million |
CN¥29.34 Million ≈ $4.29 Million |
0.170x | -19.03% |
| 2011-12-31 | CN¥144.57 Million ≈ $21.15 Million |
CN¥30.36 Million ≈ $4.44 Million |
0.210x | -8.89% |
| 2010-12-31 | CN¥117.43 Million ≈ $17.18 Million |
CN¥27.07 Million ≈ $3.96 Million |
0.230x | -23.75% |
| 2009-12-31 | CN¥70.62 Million ≈ $10.33 Million |
CN¥21.35 Million ≈ $3.12 Million |
0.302x | -- |
About Kangyue Technology Co Ltd
Changjiang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the production and distribution of pharmaceuticals and photovoltaic equipment in China and internationally. It offers photovoltaic equipment, such as laminators and stack welding machines; and Chinese herbal medicines and hollow capsules, as well as engages in pharmaceutical distribution business. The company wa… Read more